November 7, 2025 - 03:16

In a significant development for the health tech industry, Omada Health has announced the expansion of its weight management program to include the prescribing of GLP-1 medications and other obesity treatments. This move comes as the company celebrates a remarkable growth in its membership, which has now surpassed 100,000 individuals.
The introduction of these medications aims to provide a more comprehensive approach to weight management, addressing the needs of those struggling with obesity. GLP-1 receptor agonists, known for their effectiveness in promoting weight loss and improving metabolic health, will now be part of the resources available to members.
Omada Health's commitment to enhancing its offerings reflects a growing recognition of the importance of personalized care in combating obesity. As the demand for effective weight management solutions continues to rise, the company's new initiative positions it as a leader in the health tech space, promising to support individuals on their journey to better health and wellness.
March 11, 2026 - 10:56
Primary Care Is in Trouble. So Doctors Band Together To Boost Their Market Power.Facing mounting financial pressures, thousands of primary care practices across the country are forming strategic alliances to safeguard their independence and ensure viability. The traditional...
March 10, 2026 - 21:23
Minnesota's Uninsured Population Reaches Six-Year HighNew data reveals a concerning trend in Minnesota, where the rate of residents without health insurance has climbed to its highest point in six years. This significant increase marks a reversal of...
March 10, 2026 - 01:39
F.D.A. Opens Door to More Flavored E-CigarettesIn a significant shift, federal health officials have outlined a new proposal that could allow certain flavored nicotine vapes back onto the market. The plan would permit the sale of e-cigarette...
March 9, 2026 - 14:43
Newsom Picks a Dogfight With Trump and RFK Jr. on Public HealthGovernor Gavin Newsom is positioning California as a national leader in evidence-based public health, drawing a sharp contrast with the anti-vaccine rhetoric of Robert F. Kennedy Jr. and the...